PATENT CLAIM ANALYSIS

Application Number: 16314569
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "733000"]

Abstract:
The present invention relates to a cannabinoid containing oral solution. Preferably the oral solution comprises a cannabinoid, a lipid solvent, a sweetener and ethanol, characterised in that the sweetener is an ultrahigh potency sweetener.

Claim (Index 35):
A method of treating a condition in a subject having the condition, comprising administering the solution of  claim 18  to the subject, wherein the condition is selected from Dravet Syndrome, Lennox Gastaut Syndrome, myocolonic seizures, juvenile mycolonic epilepsy, refractory epilepsy, schizophrenia, juvenile spasms, West syndrome, infantile spasms, refractory infantile spasms, tuberous sclerosis complex, brain tumors, neuropathic pain, cannabis use disorder, post-traumatic stress disorder, anxiety, early psychosis, Alzheimer's Disease, and autism.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14242624', '15635499', '15514402', '14881969', '15449535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.693936987928425
- 35 USC 102 Novelty (BERT): 0.5115543834313412
- Combined Prediction Score: 0.6756987274787165
- Mean Citation Score: 195.428616
- Max Citation Score: 229.63133
- Similarity Product: 132.7099525111532

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test